Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D055496', 'term': 'Neurogenic Bowel'}], 'ancestors': [{'id': 'D003109', 'term': 'Colonic Diseases, Functional'}, {'id': 'D003108', 'term': 'Colonic Diseases'}, {'id': 'D007410', 'term': 'Intestinal Diseases'}, {'id': 'D005767', 'term': 'Gastrointestinal Diseases'}, {'id': 'D004066', 'term': 'Digestive System Diseases'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'TRIPLE', 'whoMasked': ['PARTICIPANT', 'INVESTIGATOR', 'OUTCOMES_ASSESSOR']}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 36}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2021-07-07', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2025-11', 'completionDateStruct': {'date': '2025-06-11', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2025-11-19', 'studyFirstSubmitDate': '2020-03-11', 'studyFirstSubmitQcDate': '2020-03-11', 'lastUpdatePostDateStruct': {'date': '2025-11-24', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2020-03-13', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2025-05-30', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Time required for defecation', 'timeFrame': '8 weeks', 'description': 'Time taken to have a bowel movement'}], 'secondaryOutcomes': [{'measure': 'Neurogenic bowel dysfunction score', 'timeFrame': '8 weeks', 'description': 'Participants can score between 0 and 47 (0=minimum and 47=maximum score) a higher score = greater severity of symptoms'}]}, 'oversightModule': {'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'conditions': ['Neurogenic Bowel']}, 'descriptionModule': {'briefSummary': 'A well-managed bowel program is an essential part of daily life for many people with a SCI. Nevertheless, constipation is frequently reported (42-95%). Constipation embraces a spectrum of harms including both physical \\& psychological distress. Initial exploratory studies suggest abdominal FES may be useful for decreasing overall bowel management time, decreasing colonic transit time and reducing discomfort. The current study will seek to reproduce previous findings in a 12 week study, using overall bowel management time as a benchmark for establishing proof of principle. The study will include 36 people with a spinal cord injury aged 18 and over with an above T12 injury, a complete or incomplete lesion in a medically stable condition, one year or more after injury. Participants will be randomised into two groups. One group will receive abdominal electrical stimulation and the other group low dose abdominal electrical stimulation. Participants will be asked to keep a bowel diary and complete questionnaires examining quality of life and bowel management.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'maximumAge': '100 Years', 'minimumAge': '18 Years', 'healthyVolunteers': True, 'eligibilityCriteria': '* Inclusion Criteria:\n* People with a diagnosis of spinal cord injury\n* Age =\\>18 years of age\n* Injury level at or above T12\n* complete or incomplete spinal cord lesion\n* Medically stable condition\n* Reflex bowel\n* =\\>1 year post spinal cord injury\n* Exclusion Criteria:\n* A history of organic bowel obstruction\n* Frequent opioid use,\n* Intrathecal baclofen or percutaneous endoscopic gastrostomy\n* Inflammatory bowel disease\n* Recent abdominal hernia\n* Recent gastrointestinal or abdominal surgery\n* Lower motor neuron lesions,\n* Suspected strictures or fistulae along the gastrointestinal tract\n* Physiologic gastrointestinal obstruction.\n* Other causes of constipation such as hypothyroidism, hypercalcaemia\n* Constipation predominant irritable bowel syndrome prior to diagnosis of SCI\n* Involvement in other research trial interventions likely to impact current trial\n* Poorly controlled epilepsy,\n* Cardiac pacemaker in situ\n* Other implanted electrical devices\n* Pregnancy or pregnancy planned\n* Cancerous tissue in the abdominal region\n* Any major skin disorders affecting the abdominal area)\n* Severe autonomic dysreflexia (tested at initial assessment).'}, 'identificationModule': {'nctId': 'NCT04307303', 'acronym': 'BOWMAN', 'briefTitle': 'Electrical Stimulation of Abdominal Muscles for Bowel Management in People With Spinal Cord Injury', 'organization': {'class': 'OTHER_GOV', 'fullName': 'Salisbury NHS Foundation Trust'}, 'officialTitle': 'A Randomised Sham-controlled, Proof of Principle Study of Abdominal Functional Electrical Stimulation (ABFES) for Bowel Management in Spinal Cord Injury (SCI)', 'orgStudyIdInfo': {'id': 'BOWMAN'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Abdominal functional electrical stimulation', 'interventionNames': ['Device: abdominal functional electrical stimulation']}, {'type': 'SHAM_COMPARATOR', 'label': 'Low dose abdominal functional electrical stimulation arm', 'interventionNames': ['Device: abdominal functional electrical stimulation']}], 'interventions': [{'name': 'abdominal functional electrical stimulation', 'type': 'DEVICE', 'otherNames': ['ABFES'], 'description': 'functional electrical stimulation of the abdominal muscles', 'armGroupLabels': ['Abdominal functional electrical stimulation', 'Low dose abdominal functional electrical stimulation arm']}]}, 'contactsLocationsModule': {'locations': [{'zip': 'SP2 9BJ', 'city': 'Salisbury', 'country': 'United Kingdom', 'facility': 'Salisbury NHS Foundation Trust', 'geoPoint': {'lat': 51.06931, 'lon': -1.79569}}], 'overallOfficials': [{'name': 'Tamsyn Street', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Salisbury NHS Foundation Trust'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Salisbury NHS Foundation Trust', 'class': 'OTHER_GOV'}, 'collaborators': [{'name': 'Inspire Foundation', 'class': 'UNKNOWN'}], 'responsibleParty': {'type': 'SPONSOR'}}}}